Amedisys, Inc. (NASDAQ:AMED) Given Average Recommendation of "Hold" by Brokerages

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) has earned a consensus rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $100.75.

Several research firms recently commented on AMED. Stephens reissued an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Finally, Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th.

Amedisys Stock Performance

Shares of AMED stock opened at $97.51 on Wednesday. The company's fifty day simple moving average is $94.30 and its 200-day simple moving average is $92.01. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.27. The company has a market cap of $3.20 billion, a PE ratio of 35.98, a P/E/G ratio of 1.32 and a beta of 0.94.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The business's revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm posted $1.03 earnings per share. As a group, equities research analysts anticipate that Amedisys will post 4.4 EPS for the current year.

Institutional Trading of Amedisys

A number of hedge funds have recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB boosted its holdings in Amedisys by 56.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares during the period. Blue Trust Inc. lifted its holdings in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock worth $32,000 after acquiring an additional 141 shares during the period. Xponance Inc. lifted its holdings in shares of Amedisys by 3.5% during the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after acquiring an additional 148 shares during the period. Finally, Gamco Investors INC. ET AL lifted its holdings in shares of Amedisys by 0.5% during the 4th quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after acquiring an additional 159 shares during the period. 94.36% of the stock is owned by institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.